期刊文献+

局部黏着斑激酶作为肿瘤治疗靶点的研究进展 被引量:3

Focal adhesion kinase,a novel target for cancer therapy
原文传递
导出
摘要 局部黏着斑激酶(focal adhesion kinase,FAK)是一种非受体型酪氨酸蛋白激酶,是细胞内重要的骨架蛋白与多种信号通路的关键分子。FAK在肿瘤发生、发展、迁移和侵袭的各个阶段都具有重要作用,FAK已经被当作潜在的肿瘤治疗靶点来研究。该综述将对FAK与肿瘤的关系以及FAK作为肿瘤治疗靶点的研究进展进行探讨。 Focal adhesion kinase(FAK),a cytoplasmic non-receptor protein tyrosine kinase,serves as both a molecular scaffold and a mediator participating in multiple signal transduction pathways.FAK is involved in tumor cell survival,proliferation,migration and metastasis.Currently,FAK has been regarded as a potential target for cancer therapy.This review is to summarize the relationship between FAK and tumor progression,and to discuss the strategies targeting FAK for cancer treatment.
出处 《生命科学》 CSCD 北大核心 2011年第1期7-12,共6页 Chinese Bulletin of Life Sciences
基金 澳门科技发展基金(071/2009/A3 091/2009/A)
关键词 局部黏着斑激酶 抗肿瘤 治疗 focal adhesion kinase antitumor treatment
  • 相关文献

参考文献45

  • 1Hao H, Naomoto Y, Bao X, et al. Focal adhesion kinase as potential target for cancer therapy (Review). Oncol Rep, 2009, 22 (5): 973-9.
  • 2van Nimwegen MJ, van de Water B. Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol, 2007, 73 (5): 597-609.
  • 3Lim ST, Mikolon D, Stupack DO, et al. FERM control of FAK function: implications for cancer therapy. Cell Cycle, 2008, 7 (15): 2306-14.
  • 4Harte MT, Hildebrand JD, Burnham MR, et al. p130Cas, a substrate associated with v-Src and v-Crk, localizes to focal adhesions and binds to focal adhesion kinase. J Biol Chem, 1996, 271 (23): 13649-55.
  • 5Liu Y, Loijens JC, Martin KH, et al. The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly. Mol Biol Cell, 2002, 13 (6): 2147-56.
  • 6Taylor JM, Hildebrand JD, Mack CP, et al. Characterization of graf, the GTPase-activating protein for rho associated with focal adhesion kinase. Phosphorylation and possible regulation by mitogen-activated protein kinase. J Biol Chem, 1998, 273 (14): 8063-70.
  • 7Brown MC, Perrotta JA, Turner CE. Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding. J Cell Biol, 1996, 135 (4): 1109-23.
  • 8Schaller MD. Paxillin: a focal adhesion-associated adaptor protein. Oncogene, 2001, 20 (44): 6459-72.
  • 9Schaller MD, Otey CA, Hildebrand JD, et al. Focal adhesion kinase and paxillin bind to peptides mimicking β integrin cytoplasmic domains. J Cell Biol, 1995, 130 (5): 1181-7.
  • 10Turner CE. Paxillin and focal adhesion signalling. Nat Cell Biol, 2000, 2 (12): E231-6.

同被引文献42

  • 1谭余良,殷勤伟.RNAi在癌症治疗中的应用[J].药学学报,2005,40(3):193-198. 被引量:7
  • 2Maung K,Easty DJ,Hill SP,et al.Requirement for focal adhesion kinase in tumor cell adhesion.Oncogene,1999,18 (48):6824-6828.
  • 3Golubovskaya VM,Kweh FA,Cance WG.Focal adhesion kinase and cancer,Histol Histopathol,2009,24(4):503-510.
  • 4Vang J,Pan WH,Clawson GA,et al.Systemic targeting inhibitor of kappa B kinasc inhibits melanoma tumor growth.Cancer Rcs,2007,67(7):3127-3134.
  • 5Chan KT,Cortesio CL,Huttenlocher A.FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion.Cell Biol,2009,185 (2):357-70.
  • 6Le Y,Xu L,Fang J,et al.FAK silencing inhibits leukemogenesis in BCR /ABL2 transformed hematopoietic cells.Am J Hematology,2009,84 (5):273-278.
  • 7Luo M,Fan H,Nagy T,et al.Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells.Cancer Res,2009,69(2):466-474.
  • 8Halder J,Kamat AA,Landen CN,et al.Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.Clin Cancer Res 2006,12(3):4916-4924.
  • 9Hanks SK, Pohe TR, Signaling through focal adhesion kinase [ J].Bioessays, 1997, 19 (2) : 137-145.
  • 10Shieh JM, Cheng TH, Shi MD, et al. A-tomatine suppresses invasion and migration of human non-small cell lung cancer NCI-H460 cells through inactivating FAK/PI3K/Akt signaling pathway and reducing binding activity of NF-jB [ J]. Cell Biochem Biophys, 2011, 60( 1 ) : 297-310.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部